Early research (Phase 1)Study completedNCT00457145
What this trial is testing
Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation
Who this might be right for
Telangiectasia
National Eye Institute (NEI) 5
Showing 9 of 9 results